Chair: Helen Williams, National Specialty Adviser for CVD Prevention, NHSE & Consultant Pharmacist for CVD

Speaker: Natasha Moore, Senior Renal Pharmacist GSTT

Key points:

  • Both CKD and CVD share common high impact risk factors, such as smoking, obesity, hypertension, diabetes, and dyslipidaemia.
  • Cardiovascular risk factors are often underdiagnosed and undertreated in patients with CKD.
  • Key interventions to improve outcomes in people with CKD are control of blood pressure, lipid management, regulation of blood sugar, and initiation of prognostic medications such as ACEI / ARB and SGLT2 inhibitors-

This LTC Masterclass has been sponsored by Boehringer Ingelhiem, who have had no input into the content or choice of speaker for this event.